drugset / Trial / NCT03377478

Expanding the Pool in Lung Transplantation

NCT03377478

Phase 1 Completed 10 enrolled Pablo Sanchez
NaSingle-groupOpen-labelTreatment

Summary

To perform a study (20 patients) utilizing Hepatitis C positive (HCV Ab+/NAT -) donor lungs for hepatitis C negative recipients with post-operative surveillance and treatment only if a recipient infection occurs.

Timeline

Start
2019-07-30
Primary completion
2021-09-21
Completion
2022-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject glecaprevir Other / unclassified